METROPOLIS583.00

Metropolis Healthcare Ltd.

· Pharma & Health
₹ CrorePeersLALPATHLABVIJAYATHYROCAREMARKSANSPARKHOSPSJLHLRUBICONHCGMcap ₹12,087 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)58.2264.9951.1751.17
Receivable Days (DSO)38.1740.5737.7637.76
Payable Days (DPO)149.63170.98145.56142.04
Cash Conversion Cycle (days)-53.24-65.42-56.63-53.11
Working Capital Turnover17.2625.8012.2312.71
Asset Turnover0.780.710.770.77
Cash Conversion (CFO/Net Income)2.061.811.831.83
CFO/EBITDA0.930.870.870.87
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.